Compare SLDB & MRTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLDB | MRTN |
|---|---|---|
| Founded | 2013 | 1946 |
| Country | United States | United States |
| Employees | N/A | 3502 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2017 | 1994 |
| Metric | SLDB | MRTN |
|---|---|---|
| Price | $9.29 | $14.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $16.36 | N/A |
| AVG Volume (30 Days) | ★ 893.5K | 676.4K |
| Earning Date | 05-12-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.61% |
| EPS Growth | ★ 34.97 | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | $8,094,000.00 | ★ $1,131,455,000.00 |
| Revenue This Year | N/A | $2.23 |
| Revenue Next Year | N/A | $8.59 |
| P/E Ratio | ★ N/A | $184.13 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.79 | $9.35 |
| 52 Week High | $11.45 | $18.48 |
| Indicator | SLDB | MRTN |
|---|---|---|
| Relative Strength Index (RSI) | 56.37 | 38.94 |
| Support Level | $6.25 | $14.39 |
| Resistance Level | $11.45 | $15.36 |
| Average True Range (ATR) | 0.45 | 0.36 |
| MACD | 0.09 | 0.06 |
| Stochastic Oscillator | 66.77 | 46.97 |
Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.
Marten Transport Ltd is a temperature-sensitive and dry truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. The company operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services transporting food and other consumer packaged goods.